Recent advances in the management of late paracetamol poisoning

Emergency Medicine

Volumn 12, Issue 1, 2000, Pages 14-21

  Jones, Alison L ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acetaminophen; Fulminant hepatic failure; Late poisoning; Paracetamol

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

DRUG INTOXICATION; DRUG MECHANISM; DRUG OVERDOSE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; REVIEW;

EID: 0034031190     PISSN: 14410737     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2000.00088.x     Document Type: Review

References (54)

1. Babbage NF. Alternatives to non-steroidal anti-inflammatory drugs. Med. J. Aust. 159: 429-30.
2. Hawton K, Fagg J. Trends in deliberate self-poisoning and self-injury in Oxford, 1976-90. BMJ 1992; 304: 1409-11.
3. Brotodihardjo AE, Batey RG, Farrell GC, Byth K. Hepatotoxicity from paracetamol self-poisoning in western Sydney. Med. J. Aust. 1992; 157: 382-5.
4. Sheil AG, McCaughan CW, Thompson JF et al. Liver transplantation: An Australian experience. Clin. Transpl. 1990; 13: 144-5.
5. Vale JA, Buckley BM, Meredith TJ. Deaths from paracetamol and dextropropoxyphene (distalgesic) poisoning in England and Wales. Hum. Toxicol. 1984; 3: S135-143.
6. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharm. Exp. Ther. 1973a; 187: 185-91.
7. Mitchell JR, Jollow DJ, Gillette JR, Brodie BB. Drug metabolism as a cause of drug toxicity. Drug Metab. Dispos. Biol. Fate Chem. 1973b; 1: 418-23.
8. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin. Pharm. Ther. 1974; 16: 676-84.
9. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharm. Exp. Ther. 1973c; 187: 211-17.
10. Prescott LF, Illingworth RN, Critchley JA, Proudfoot AT. Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning. BMJ 1979; 2: 1097-100.
11. Prescott LF. Paracetamol (acetaminophen). A Critical Bibliographic Review. London: Taylor & Francis, 1996.
12. Fellay M, Kehtari R. Insuffisance hépatique fulminante et subfulminante. Rev. Med. Suisse Romande 1996; 116: 483-91 (in French).
13. Rubin E, Lieber CS. Hepatic microsomal enzymes in man and rats: Induction and inhibition by ethanol. Science 1968; 162: 690-1.
14. Pessayre D, Dolder A, Artigou JY et al. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology 1979; 77: 264-71.
15. Prescott LF, Critchley JA. Drug interactions affecting analgesic toxicity. Am. J. Med. 1983; 75: 113-16.
16. Johnston SC, Pelletier Jr LL. Enhanced hepatotoxicity of acetaminophen in the alcoholic patients. Two cases reports and a review of the literature. Medicine (Balt) 1997; 76: 185-91.
17. Kumar S, Rex DK. Failure of physicians to recognise paracetamol toxicity in chronic alcoholics. Arch. Int. Med. 1991; 151: 1189-91.
18. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: A therapeutic misadventure. Ann. Int. Med. 1986; 104: 399-404.
19. Blatzka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 1995; 133: 43-52.
20. de la Mata M, Megar A, Rolando N et al. Tumour necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection. Clin. Exper. Immunol. 1990; 82: 479-84.
21. Lawson JA, Fisher MA, Simmons CA, Farhood A, Jaeschke H. Inhibition of FAS-receptor (CD 95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice. Toxicol. Appl. Pharmacol. 1999; 156: 179-86.
22. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Schaffer F, Popper H (eds). Progress in Liver Disease. New York: Grune and Stratton, 1970; 282-98.
23. Ellis A, Wendon J. Circulatory, respiratory, cerebral and renal derangements in acute liver failure: Pathophysiology and management. Semin. Liver Dis. 1996; 16: 379-88.
24. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the National Multicenter Study (1976-85). N. Engl. J. Med. 1988; 319: 1557-62.
25. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572-4.
26. Keays R, Harrison PM, Wendon JA et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991; 303: 1026-9.
27. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: A 48 hour IV N-acetylcysteine treatment protocol. Ann. Emerg. Med. 1991; 20: 1058-63.
28. Viallon A, Lafond P, Tardy B, Zeni F, Page Y, Bertrand JC. Perfusion tardive de N-acétylcystéine dans un d'intoxication au paracétamol vu au stade d'une hépatite fulminate. Therapie 1994; 49: 144-6 (in French).
29. Rey C, Ajzenberg N, Tchernia G, Alvin P, Dreyfus M. Insuffusance hépatocellular aiguë au paracéetamol: faut-il prolonger la durée du traitement par la N-acétyl cystéine? Arch Pediatr. 1995; 2: 662-5 (in French).
30. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med. 1991; 324: 1852-7.
31. Walsh TS, Hopton P, Phillips B, Mackenzie SJ, Lee A. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 1998; 27: 1332-40.
32. Walsh TS, Hopton P, Lee A. A comparison between the Fick and indirect calorimetry for determining oxygen consumption in patients with fulminant hepatic failure. Crit. Care Med. 1998; 26: 1200-7.
33. Bartlett RH, Dechert RE. Oxygen kinetics; Pitfalls in clinical research. J. Crit. Care 1990; 5: 77-80.
34. Archie JP. Mathematic coupling of data. A common source of error. Ann. Surg 1981; 193: 296-303.
35. Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am. J. Respir. Crit. Care Med. 1994; 149: 533-7.
36. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit. Care Med. 1997; 25: 236-12.
37. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407-13.
38. Tee LGB, Boobis AR, Davies DS. N-acetylcysteine for paracetamol overdose. Lancet 1986; i: 331-2.
39. Arouma OI, Halliwell B, Hey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Radic. Biol. Med. 1989; 6: 593-7.
40. Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. In: Mc Intyre NM, Benhamou JP, Rodes J et al. (eds.). Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, 1991; 923-42.
41. Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production. Meth. Find. Exp. Clin. Pharmacol. 1993; 15: 101-5.
42. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med. J. Aust. 1989; 150: 1329-331.
43. Flanagan RJ, Meredith TJ. Use of N-acetylcysteine in clinical toxicology. Am. J. Med. 1991; 91: S131-139.
44. Stavem K. Anaphylactic reaction to N-acetylcysteine after poisoning with paracetamol. Tidsskr. Nor. Laegeforen 1997; 117: 2038-9.
45. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-93). Gastroenterology 1995; 109: 1907-16.
46. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of poor prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
47. Ware AJ, D'Agostinio AN, Coombes B. Cerebral edema: A major complication of massive hepatic necrosis. Gastroenterology 1971; 61: 877-84.
48. Lee WM. Acute liver failure. Am. J. Med. 1994; 96: S3-9.
49. Harrison PM, O'Grady JG, Keays RT, Alexander GJ, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990; 301: 964-6.
50. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995; 45: 163-9.
51. O'Grady JG, Wendon J, Tan KC et al. Liver transplantation after paracetamol overdose. BMJ 1991: 303: 221-3.
52. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: Definition and causes. Semin. Liv. Dis. 1986; 6: 97-106.
53. Forster J, Bartholme WG, Qelcore R. Should a patient who attempted suicide receive a liver transplant ? J. Clin. Ethics 1996; 7: 257-67.
54. Surman OS. Psychiatric aspects of liver transplantation. Psychosomatics 1994; 35: 297-307.